Coronary Stent Market-By Product, By Design, By End User, and By Region-Global Outlook and Forecast 2024

SDKI Inc. is a coronary stent market survey aimed at providing a detailed analysis of several aspects of the market, including market growth drivers, opportunities, recent trends and challenges between 2018-2024.

Report sample URL
https://www.sdki.jp/sample-request-91500

The global coronary stent market is estimated to reach over US $ 11 billion by 2024 and is expected to grow at a CAGR of approximately 7% between 2018-2024.

The emergence of bioabsorbable vascular scaffolds, the high growth potential of 3rd generation DES with thin struts, technological advances and innovations, and the approval and launch of new products will drive market growth over the next few years. Expected. In addition, the increased prevalence of cardiovascular disease (CVD), especially vascular disease, is a major driver of growth in the coronary stent market. Over the years, coronary stents have witnessed several technological advances, especially design innovations. Due to the high prevalence of coronary artery disease, stent manufacturers

focus primarily on R & D activities and the commercialization of innovative drug-eluting stent (DES) systems.

Report sample URL
https://www.sdki.jp/sample-request-91500

Market Segments
The coronary stent market is divided by product, design, end user, and region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period. The detailed market

Regional Overview
The coronary stent market is further subdivided based on the region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, and other Asia Pacific). ) And other regions.

North America held half of the global coronary stent market share in 2018. Factors such as the presence of a large patient population using CAD requiring coronary stents, high acceptance of advanced and innovative cardiac stents, and high awareness of stent-based PCI procedures are the dominant share of the North American market. Is expected to contribute to. Germany, the United Kingdom, France, Italy, and Spain, on the other hand, are major revenue contributors to the European coronary stent market. The presence of a highly sophisticated healthcare infrastructure, high awareness of the benefits of PCI procedures, and increased R & D investment in innovative coronary stents are key drivers of growth in the European coronary stent market. It's power.

Details of the survey report
https://www.sdki.jp/reports/coronary-stents-market/91500

Key Players on the Market

Key players on the coronary stent market include Abbott, Boston Scientific, Medtronic, Terumo, Braun Melsungen, and Biosensors International.

Group, Arterial Remodeling Technologies, Alvimedica, Balton, Cardionovum, CeloNovaBioSciences, Comed, Cordis, Elixir Medical, Endocor, Eucatech, Eurocor Tech, Hexacath, InSitu Technologies and more. The study includes a detailed competitive analysis of these major companies in the coronary stent market, corporate profiles, recent developments, and key market strategies.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.